Adaptive Biotechnologies raises 2026 MRD revenue guide to $276M-$286M as it targets $1,700-$1,800 ASP
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Colgate-Palmolive vs. Hershey: Which Consumer Goods Stock Is the Better Buy for 2027?
Key PointsColgate-Palmolive’s trailing-12-month revenue grew about 6% to $21 billion, with $3.8 billion in free cash flow.
Razorpay gets SEBI approval for IPO, eyeing $5b valuation
Razorpay’s revenue grew 24% in FY24 to 20.7 billion rupees (US$219 million).
China’s Copper Squeeze Deepens as Buyers Scramble for Spot Metal
Copper buyers in China are scrambling for physical metal, with spot premiums soaring as supplies tighten sharply in the world’s biggest consumer.